SABCS

Latest SABCS News

Add-On Inavolisib Ups PFS in PIK3CA-Mutated Breast Cancer

SAN ANTONIO -- The addition of inavolisib to palbociclib (Ibrance) plus fulvestrant

Derick Alison Derick Alison

Bispecific Antibody Combination Active in Metastatic HR+/HER2+ Breast Cancer

SAN ANTONIO -- Combination therapy including a bispecific antibody targeting HER2 showed

Derick Alison Derick Alison

Less-Frequent Surveillance Mammo Feasible in Older Breast Cancer Survivors

SAN ANTONIO -- Women ages >50 who de-escalated to less-frequent mammography 3

Derick Alison Derick Alison

Bilateral Mastectomy Not Tied to Better Survival in BRCA1-Positive Breast Cancer

SAN ANTONIO -- Bilateral mastectomy as initial treatment for women with breast

Derick Alison Derick Alison

Is Omitting Radiation Therapy in Low-Risk Breast Cancer a Good IDEA?

SAN ANTONIO -- Postmenopausal women with genomically low-risk early hormone receptor (HR)-positive

Derick Alison Derick Alison

Study Supports ADC as a New Option for Endocrine-Resistant Metastatic Breast Cancer

SAN ANTONIO -- The investigational Trop2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd)

Derick Alison Derick Alison

Maintenance Pembrolizumab-Olaparib Fails to Boost Survival in TNBC

SAN ANTONIO -- A maintenance strategy involving checkpoint blockade and a PARP

Derick Alison Derick Alison

Study ‘Underscores’ Value of Early Fertility Counseling for Breast Cancer Patients

SAN ANTONIO -- Using fertility preservation and/or assisted reproductive technologies (ART) did

Derick Alison Derick Alison

Adding Immunotherapy to Neoadjuvant Chemo Boosts pCR in HR-Positive Breast Cancer

SAN ANTONIO -- Adding an immune checkpoint inhibitor (ICI) to chemotherapy significantly

Derick Alison Derick Alison

No Benefit to Adjuvant-Only Immunotherapy in Early TNBC

SAN ANTONIO -- Adjuvant-only immunotherapy with atezolizumab (Tecentriq) added to a standard

Derick Alison Derick Alison
adbanner